Resource utilization and healthcare management of invasive versus non-invasive strategy for cardiac allograft vasculopathy surveillance in heart transplantation
J Cardiovasc Comput Tomogr. 2024 Nov 29:S1934-5925(24)00498-2.
doi: 10.1016/j.jcct.2024.11.002.
Online ahead of print.
1 Cardiovascular Center Aalst, OLV-Clinic, Aalst, Belgium; Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy.
2 Cardiovascular Center Aalst, OLV-Clinic, Aalst, Belgium; IRCCS Ospedale Galeazzi Sant'Ambrogio, Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
3 Cardiovascular Center Aalst, OLV-Clinic, Aalst, Belgium.
4 Cardiology Unit, IRCCS Azienda Ospedaliera-Universitaria di Bologna, Bologna, Italy; Department of Medical and Surgical Sciences - DIMEC - Alma Mater Studiorum, University of Bologna, Bologna, Italy.
5 IRCCS Ospedale Galeazzi Sant'Ambrogio, Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
6 Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy.
7 Department of Clinical and Molecular Medicine, Sapienza University of Rome, Italy; Cardiology Unit, Sant'Andrea University Hospital, Rome, Italy.
8 Heart Center, University Hospital Ghent, Belgium.